Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841771
Status:
RECRUITING
Last Update Posted:
2023-05-08
First Post:
2023-04-24
Brief Title:
Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies
Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization Data
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Class:
OTHER
Study ID:
SHSYXY-AZA-VEN-202301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Liping Wan
Responsible Party Title:
Associate Director of Department of Hematology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Old Name:
None
Old Organization:
None